Usage of beta blockers (BB) in the treatment of heart failure is based on solid clinical evidences. However, in the daily practice several issues related to this treatment appear – selection of the right drug, dosage, relationship with other treatments, with comorbid conditions, etc. Our study – on the basis of clinical evidences – presents practice guidelines concerning the main aspects of BB treatment, with special accent on the selection of the optimal drug. In the same time, the experience/customs of our clinic in this area is presented using restrospective data obtained in 115 patients (99 men, mean age 66 years, stage NYHA II-IV) admitted with systolic heart failure.
Keywords: heart failure, beta blocker treatment